Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain
Status:
Unknown status
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This research study because is looking at woman with symptoms of chronic pelvic pain caused
by short, tight, and tender pelvic floor muscles (Myofascial Pelvic Pain syndrome). The
purpose of this study is to determine whether or not injections with onabotulinumtoxinA
(Botox) improve symptoms of pain and tenderness. The drug being studied, Botox is FDA
approved for other uses. However, Botox is not FDA approved for the use in myofascial pelvic
pain (MPP). Therefore, Botox is considered experimental or research in this study.
Phase:
Phase 1
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA